Valuation: Hypera S.A.

Market Cap 1.49TCr 288.82Cr 247.4Cr 231.49Cr 211.9Cr 397.67Cr 28TCr 402.93Cr 2.73TCr 1.07TCr 14TCr 1.08TCr 1.06TCr 46TCr P/E 2026 *
7.79x
P/E 2027 * 6.57x
Enterprise Value 2.1TCr 407.41Cr 348.99Cr 326.54Cr 298.91Cr 560.96Cr 39TCr 568.38Cr 3.86TCr 1.5TCr 20TCr 1.53TCr 1.5TCr 65TCr EV / Sales 2026 *
2.29x
EV / Sales 2027 * 2.03x
Free-Float
38.88%
Yield 2026 *
5.56%
Yield 2027 * 5.28%
1 day-1.15%
1 week+2.63%
Current month+2.87%
1 month+7.63%
3 months-2.49%
6 months-2.27%
Current year+3.93%
1 week 3.96
Extreme 3.96
4.3
1 month 3.75
Extreme 3.75
4.3
Current year 3.75
Extreme 3.75
5.5
1 year 3.71
Extreme 3.71
5.5
3 years 2.64
Extreme 2.64
8.38
5 years 2.64
Extreme 2.64
10.08
10 years 2.64
Extreme 2.64
11.98
Manager TitleAgeSince
Chief Executive Officer 50 24/04/2019
Director of Finance/CFO 38 24/02/2022
Chief Operating Officer 40 01/01/2020
Director TitleAgeSince
Director/Board Member 77 01/06/2007
Director/Board Member 60 01/06/2007
Director/Board Member 52 26/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%+2.63% - - 288.82Cr
+0.88%+6.38%+76.40%+126.75% 1,11900Cr
+1.07%+3.80%+50.73%+62.78% 65TCr
+1.20%+6.21%+25.81%+78.74% 47TCr
+1.02%+5.77%+43.63%+48.43% 37TCr
+0.85%+4.07%+24.97%+40.58% 30TCr
+1.26%+6.81%+2.27%+14.41% 26TCr
+1.88%+5.81%+49.57%+70.53% 24TCr
+1.59%+2.09%-17.33%-52.62% 21TCr
+1.87%+5.61%+27.32%+91.38% 18TCr
Average +1.05%+4.97%+31.49%+53.44% 42.22TCr
Weighted average by Cap. +1.14%+5.09%+44.26%+72.65%

Financials

2026 *2027 *
Net sales 919.87Cr 178.26Cr 152.7Cr 142.88Cr 130.79Cr 245.45Cr 17TCr 248.69Cr 1.69TCr 658.29Cr 8.57TCr 669.36Cr 654.79Cr 28TCr 999.99Cr 193.79Cr 166Cr 155.32Cr 142.18Cr 266.83Cr 19TCr 270.36Cr 1.84TCr 715.63Cr 9.31TCr 727.66Cr 711.83Cr 31TCr
Net income 191.18Cr 37Cr 32Cr 30Cr 27Cr 51Cr 3.54TCr 52Cr 350.83Cr 136.81Cr 1.78TCr 139.11Cr 136.09Cr 5.89TCr 222.49Cr 43Cr 37Cr 35Cr 32Cr 59Cr 4.13TCr 60Cr 408.3Cr 159.22Cr 2.07TCr 161.9Cr 158.38Cr 6.85TCr
Net Debt 611.96Cr 118.59Cr 101.59Cr 95Cr 87Cr 163.29Cr 11TCr 165.45Cr 1.12TCr 437.94Cr 5.7TCr 445.3Cr 435.61Cr 19TCr 535.31Cr 103.74Cr 89Cr 83Cr 76Cr 142.84Cr 9.93TCr 144.72Cr 982.34Cr 383.08Cr 4.99TCr 389.52Cr 381.05Cr 16TCr
Logo Hypera S.A.
Hypera (formerly Hypermarcas) is the Brazilian leader in the manufacture and marketing of pharmaceutical products. The products are sold primarily under the Addera D3, Adocyl, AdultMax, Alivium, Apracur, Atroveran, Benegrip, Bigfral, Biotonico Fontoura, Coristina, Cremer, Doril, Engov, Epocler, Lisador and Neo Quimica. The activity is organized around 3 families of products : - OTC medicines; - prescription medicines; - branded generic medicines.
Employees
10,564
Date Price Change Volume
21/26/21 $4.100 +1.23% 944
20/26/20 $4.050 -0.25% 5,648
19/26/19 $4.060 +1.75% 6,530
18/26/18 $3.990 -3.62% 2,258
17/26/17 $4.140 -1.19% 1,021
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
21.17BRL
Average target price
29.17BRL
Spread / Average Target
+37.77%

Quarterly revenue - Rate of surprise